DrugPatentWatch Database Preview
« Back to Dashboard
The generic ingredient in SUCRAID is sacrosidase. One supplier is listed for this compound. Additional details are available on the sacrosidase profile page.
Generic Entry Opportunity Date for 020772
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for NDA: 020772
Profile for product number 001
|Active Rx/OTC/Discontinued:||RX||Dosage:||SOLUTION;ORAL||Strength||8,500 IU/ML|
|Approval Date:||Apr 9, 1998||TE:||RLD:||Yes|
|Patent:||➤ Try a Free Trial||Patent Expiration:||Feb 7, 2034||Product Flag?||Y||Substance Flag?||Y||Delist Request?|
Complete Access Available with Subscription